Skip to main content

News

30 Mar, 2016 Objective 3: GHP Trial Updates (February - March 2016)
The GHP Oral Antihypertensive Trial aims to compare the efficacy of oral labetalol, oral nifedipine, and oral methyldopa for the management of severe hypertension in pregnant women. The study is enrolling at two sites in Nagpur, India: Government Medical College (GMC) and Daga Women’s Hospital. GHP enrollment graph as of February 2016. GHP have enrolled 292 women as of... Read More
30 Mar, 2016 Global Pregnancy Collaboration (CoLab): Updates (February - March 2016)
We are excited to announce that the Global Pregnancy Database will soon go live. Final checking of the database is ongoing and editorials publicizing its launch are in progress. This database will be state of the art, internet based, and available for a nominal fee for investigators worldwide. It will be made available at no charge to low-and-middle income (LMIC) investigators... Read More
23 Feb, 2016 CLIP NIGERIA UPDATE
The CLIP Trial (Community Level Interventions for Pre-eclampsia) was initiated in Ogun State, Nigeria on February 2012 with a 12-month Feasibility study to identify barriers and facilitators to the proposed Trial. A Pilot study commenced April 2014 in four Local Government Areas (LGAs) of the State and the Definitive Trial commenced in ten LGAs April 2015. Logistical... Read More
4 Feb, 2016 Preeclampsia Foundation is currently accepting applications for our 2016 Vision Grant award program
The Preeclampsia Foundation announced at the Society for Maternal-Fetal Medicine's (SMFM) 36th Annual Meeting - The Pregnancy Meeting™ - that applications are now being accepted for its 2016 Vision Grant program. Up to two medical research Vision Grants will be awarded to study preeclampsia and related hypertensive disorders of pregnancy, up to $20,000 each. Vision... Read More
29 Jan, 2016 PlGF Calculator Available Online
The full PIGF calculator is now embedded in the CoLab section of the PRE-EMPT website. The purpose of this calculator is to compare the PlGF value to the CoLab Cohorts 5% threshold.The calculator works with the RnD, Alere, Eclesys, and Abbott platforms, and requires the gestational age at measurement.  The simplified version can calculate one dataset at... Read More
29 Jan, 2016 Economic Evaluation of the CLIP Pakistan Trial Site Visit
Asif Raza with provincial level health officials in Pakistan. Asif Raza Khowaja, PhD student, is currently in Pakistan collecting data for the economic evaluation of the CLIP Pakistan Trial. The first week of has been filled with many activities: meetings and discussions were held with the CLIP Pakistan team, training of senior research assistants on cost data collection... Read More
29 Jan, 2016 Objective 3: CLIP Trial Updates (December-January 2016)
 CLIP enrollment graph from February 2014 - January 2016 The CLIP Trial has enrolled 70,726 pregnancies to date including 13,997 pregnancies in India; 26,099 pregnancies in Pakistan; 25,710 pregnancies in Nigeria; and 4,920 pregnancies in Mozambique. We would like to thank all the sites for their tremendous efforts. The APEs (Agente Polivalentess Elementares), the... Read More
29 Jan, 2016 EMPOWER Program Receives 16 Letters of Intent
Collaboration Advances Preeclampsia Research in Low- and Middle-Income Countries The EMPOWER Program has received 16 Letters of Intent in response to its request for research proposals related to pre-eclampsia and other hypertensive disorders of pregnancy from young investigators in low resource settings. Of the 16 proposals, six project that were deemed feasible  have... Read More
29 Jan, 2016 Global Pregnancy Collaboration (CoLab): Updates (December-January 2016)
Since September, CoLab members have been working to follow up on the ideas developed in response to presentations at our annual meeting in Oxford. The working groups envisioned at the meeting have been formed, and they have begun to move toward possible funding strategies to explore these new ideas. One group plans to determine the cardiovascular risk factors prior to... Read More
29 Jan, 2016 Objective 3: GHP Trial Updates (December - January 2016)
GHP Trial enrollment graph as of December 2015. The GHP Oral Antihypertensive Trial aims to compare the efficacy of oral labetalol, oral nifedipine, and oral methyldopa for the management of severe hypertension in pregnant women. The study is enrolling in two sites in Nagpur, India: Government Medical College (GMC) and Daga Women’s Hospital. The GHP Trial has enrolled... Read More

Pages